Dura, Procter & Gamble deal

DURA will purchase the Entex brand product line of prescription upper respiratory drugs from P&G's Procter & Gamble Pharmaceuticals Inc. division for $45 million. The product line posted $42 million in revenues in 1995. The consumer company had not been actively marketing the products after shifting its focus to products with international growth opportunities. As a result, Entex sales declined about 20 percent last year, according to DURA, which estimated 1996 sales of $30-$35 million. ...